Bhatnagar Anish is CEO at SOLENO THERAPEUTICS INC (SLNO). They have made 15 open-market trades across 2 companies since 2015, most recently 2026-01-21.
CIK 0001614821
3 open-market purchases totalling $32K since 2015, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLNO | SELL | 2025-03-27 | 2025-03-31 | $67.62 | $94.5M | -10.3% | +6.8% | +19.5% |
| SLNO | SELL | 2025-01-02 | 2025-01-06 | $45.78 | $1.9M | +2.2% | +11.2% | +51.8% |
| SLNO | SELL | 2024-10-01 | 2024-10-03 | $49.39 | $2.0M | +10.8% | +14.8% | -6.5% |
| SLNO | SELL | 2024-08-28 | 2024-08-30 | $47.43 | $10.9M | +0.0% | +1.8% | +6.3% |
| SLNO | SELL | 2024-08-05 | 2024-08-07 | $45.60 | $11.6M | +19.4% | +13.2% | +31.5% |
| SLNO | SELL | 2024-07-01 | 2024-07-03 | $41.54 | $1.6M | +25.4% | +18.6% | +20.8% |
| SLNO | SELL | 2024-04-01 | 2024-04-03 | $41.34 | $1.6M | -6.0% | +10.2% | -3.0% |
| SLNO | SELL | 2024-01-25 | 2024-01-29 | $48.30 | $244K | -0.9% | +5.4% | -5.0% |
| SLNO | SELL | 2023-12-11 | 2023-12-13 | $35.59 | $5.4M | +5.0% | +9.5% | +15.0% |
| SLNO | SELL | 2023-11-30 | 2023-12-04 | $28.65 | $1.6M | +33.0% | +28.9% | +69.0% |
| SLNO | SELL | 2023-11-28 | 2023-11-30 | $27.49 | $2.9M | +27.7% | +30.1% | +73.2% |
| SLNO | SELL | 2022-01-21 | 2022-01-25 | $0.37 | $14K | -2.0% | -7.4% | -42.9% |
| CAPN | BUY | 2016-08-19 | 2016-08-22 | $0.96 | $10K | -4.7% | -5.7% | -10.4% |
| CAPN | BUY | 2016-05-13 | 2016-05-16 | $1.15 | $6K | +15.3% | +6.8% | -23.7% |
| CAPN | BUY | 2015-08-12 | 2015-08-13 | $1.64 | $16K | -32.5% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.